BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4034147)

  • 1. Cell surface alterations in murine leukaemia P388 adriamycin-resistant cells: studies on lectin-induced agglutination and rearrangement of lectin receptors.
    Basrur VS; Chitnis MP; Menon RS
    Oncology; 1985; 42(5):328-31. PubMed ID: 4034147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
    Basrur VS; Chitnis MP; Menon RS
    Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A; Glaubiger D; Weintraub H
    Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Capranico G; Dasdia T; Zunino F
    Int J Cancer; 1986 Feb; 37(2):227-31. PubMed ID: 3943921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
    Ramu A; Spanier R; Rahamimoff H; Fuks Z
    Br J Cancer; 1984 Oct; 50(4):501-7. PubMed ID: 6487516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
    Chitnis MP; Kamath NS
    Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.
    Radel S; Fredericks W; Mayhew E; Baker R
    Cancer Chemother Pharmacol; 1990; 25(4):241-6. PubMed ID: 1967228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
    Parekh H; Chitnis M
    Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP; Brown GA; Goldenberg GJ
    Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of clofibrate on adriamycin cytotoxicity in P388 murine leukemia cells sensitive and resistant to adriamycin.
    Chitnis M; Parekh H; Satyamoorthy K
    Tumori; 1989 Apr; 75(2):100-5. PubMed ID: 2741213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK; Chitnis MP; Embrey WM; Gregory EB
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.
    Bose R; Lam HY
    Cancer Chemother Pharmacol; 1988; 21(1):14-8. PubMed ID: 3342461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing membrane alterations associated with anthracycline resistance using fluorescent dyes.
    Kessel D
    Biochem Pharmacol; 1988 Nov; 37(22):4253-6. PubMed ID: 3196354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.